This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Click here for Vydura® (rimegepant) UK Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
VYDURA is indicated for:1
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim…
To learn more about Vydura and it's impact on Calcitonin Gene-Related Peptide Receptors, visit the Mechanism of Action page
Acute treatment of migraine with or without aura in adults.1
Preventive treatment of episodic migraine in adults who have at least 4 migraine attacks per month.1
Discover VYDURA’s safety and tolerability profile
Review a study comparing
galcanezumab versus Vydura for prevention of episodic migraine
A suite of downloadable PDFs intended for either HCPs or patients, to support with the management of migraine
To receive tailored marketing information from Pfizer by email, sign up here.
Learn more about migraines including how to diagnose, the imact on patients and society, patient views, pathopysiological and complete case-based learning.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2025 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024.